Gevo Inc. (NASDAQ:GEVO) released its quarterly earnings data on Monday. The company reported ($0.09) EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.09). Gevo had a negative return on equity of 67.50% and a negative net margin of 133.03%. The business had revenue of $6.90 million for the quarter, compared to analyst estimates of $9.12 million.

Shares of Gevo (NASDAQ:GEVO) opened at 0.351 on Wednesday. Gevo has a 52-week low of $0.22 and a 52-week high of $1.54. The stock’s market cap is $17.23 million. The firm has a 50-day moving average price of $0.42 and a 200 day moving average price of $0.48.

Earnings History for Gevo (NASDAQ:GEVO)

Separately, Zacks Investment Research upgraded Gevo from a “hold” rating to a “buy” rating and set a $0.50 price objective on the stock in a research report on Friday, August 12th.

A number of large investors have recently bought and sold shares of GEVO. KBC Group NV boosted its stake in Gevo by 40.8% in the third quarter. KBC Group NV now owns 240,843 shares of the company’s stock valued at $116,000 after buying an additional 69,743 shares during the last quarter. Vanguard Group Inc. boosted its stake in Gevo by 357.0% in the second quarter. Vanguard Group Inc. now owns 815,973 shares of the company’s stock valued at $481,000 after buying an additional 637,440 shares during the last quarter. State Treasurer State of Michigan boosted its stake in Gevo by 8.9% in the second quarter. State Treasurer State of Michigan now owns 836,448 shares of the company’s stock valued at $494,000 after buying an additional 68,301 shares during the last quarter. Finally, BlackRock Institutional Trust Company N.A. boosted its stake in Gevo by 218.6% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 1,593,285 shares of the company’s stock valued at $768,000 after buying an additional 1,093,145 shares during the last quarter. Hedge funds and other institutional investors own 3.95% of the company’s stock.

Gevo Company Profile

Gevo, Inc (Gevo) is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock.

5 Day Chart for NASDAQ:GEVO

Receive News & Stock Ratings for Gevo Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo Inc. and related stocks with our FREE daily email newsletter.